A fistula in Crohn’s disease is an abnormal, epithelium-lined tunnel that connects two surfaces, most often the inflamed bowel to nearby skin, bowel, bladder, or vagina. It forms when chronic transmural inflammation penetrates the intestinal wall and a pressure gradient pushes the tract outward. Fistulas occur in roughly 20 to 30 percent of people with Crohn’s over their lifetime and range from simple, surgically curable tracts to complex, recurrent networks. Healing depends on controlling inflammation, draining infection, and sometimes reconstructing anatomy.
How the tunnel forms
Crohn’s inflammation is not confined to the mucosa. It is transmural, meaning it reaches through the full thickness of the bowel wall. Deep ulcers and micro-abscesses erode outward, and when the serosa is breached, the inflammatory track can connect to an adjacent organ or the skin. This is why fistulas cluster in regions where loops of bowel sit against other structures, especially the terminal ileum and perianal tissue.
Two forces sustain the tract. First, a pressure gradient: intraluminal bowel pressure exceeds surrounding tissue pressure, so a path of least resistance opens outward. Second, epithelialization: the channel becomes lined with epithelium, which prevents it from simply closing like a normal wound. A fistula is therefore not just a hole but a structured, self-maintaining tract.
Fistulas are classified as simple (single tract, no abscess, no stricture, low) or complex (multiple tracts, abscess, stricture, or involvement of sphincter muscle). This distinction drives treatment more than location alone, because complex tracts carry higher recurrence and continence risk.
Quantified context
Roughly one in five to one in three people with Crohn’s develops a fistula during their disease course, with perianal fistulas the most common subtype. Perianal disease can precede intestinal symptoms in a minority of patients, which is why a persistent perianal abscess or draining tract warrants gastrointestinal evaluation.
Fistula behavior differs by location. Perianal tracts have high recurrence because the anal sphincter complex and continence mechanism are involved. Enterocutaneous fistulas often arise after surgery or in severe disease and can cause fluid and electrolyte losses. Enterovesical (bowel-to-bladder) fistulas cause recurrent urinary infections and pneumaturia.
| Fistula type | Typical connection | Common presentation | Main risk |
|---|---|---|---|
| Perianal | Anal canal to skin | Draining tract, abscess, pain | Continence loss, recurrence |
| Enterocutaneous | Bowel to skin | Output, skin breakdown | Fluid and electrolyte loss |
| Enterovesical | Bowel to bladder | Recurrent UTI, pneumaturia | Sepsis, kidney involvement |
| Enterovaginal | Bowel to vagina | Vaginal drainage, passage of gas | Infection, fistula persistence |
| Enteroenteric | Bowel to bowel | Often asymptomatic | Malabsorption, bypass |
| Rectovaginal | Rectum to vagina | Vaginal drainage | Continence and hygiene burden |
Edge cases and counterintuitive findings
The counterintuitive detail: a fistula can be completely asymptomatic and require no intervention. Enteroenteric tracts found incidentally may be left alone if they cause no obstruction, malnutrition, or sepsis. Treatment is driven by symptoms and complications, not by the mere presence of a tract.
Another caveat: healing rates in trials often look better than real-world outcomes because trials select patients and define healing by imaging or clinical closure separately. Clinical closure and imaging closure are not the same, and a tract can look closed on exam while remaining active on MRI. This is why professional societies emphasize combined assessment.
Perianal fistulas in particular demand caution. Repeated drainage procedures or aggressive probing can injure the sphincter and cause incontinence, so imaging guidance (pelvic MRI or endoanal ultrasound) is used before surgical planning. Seton placement drains the tract and preserves the sphincter rather than cutting through it.
Practical actions and thresholds
Practical management follows a sequence: control infection, control inflammation, then assess for closure, and consider surgery only when the tract is defined.
Red flag: fever, spreading redness, severe perianal pain, or inability to urinate suggests an abscess or sepsis and needs urgent evaluation. Red flag: high-output enterocutaneous drainage, dizziness, or reduced urine output suggests volume depletion and electrolyte loss. Red flag: pneumaturia, fecaluria, or recurrent urinary infections suggests an enterovesical fistula. Red flag: new vaginal drainage of stool or gas suggests a rectovaginal or enterovaginal tract. Get imaging before any surgical probing of a complex or recurrent tract. Do not delay care for a painful perianal swelling; abscess drainage is time-sensitive.
Thresholds vary by source and must be reconciled explicitly. Definitions of clinical remission differ, imaging remission differs from symptom remission, and surgical readiness depends on nutrition and infection control. A tract that is closed on exam but active on MRI is not necessarily healed. A tract that is asymptomatic may avoid surgery even if it persists. The consistent rule is that infection and malnutrition are corrected before definitive repair.
How treatment changes the tract
Medical therapy targets the inflammation that sustains the tract. Biologic agents, particularly anti-TNF therapy, can promote fistula closure in a subset of patients, but response is partial and closure rates vary widely across studies. Antibiotics and immunomodulators are used adjunctively. The key mechanism-level point is that reducing transmural inflammation reduces the driving pressure and inflammatory track, but it does not remove an already epithelialized channel.
Surgical options depend on anatomy. Seton drainage preserves sphincter function. Fistulotomy is reserved for simple, low tracts that do not cross significant sphincter muscle. Advancement flaps and ligation of the intersphincteric fistula tract are sphincter-sparing options for complex disease. Proctectomy is a last resort for uncontrollable perianal sepsis or incontinence.
Time course
Fistula healing is slow and staged. The timeline below reflects typical phases, not guaranteed outcomes.
| Phase | Typical timing | What happens |
|---|---|---|
| Abscess drainage | Days | Infection controlled, pain relieved |
| Seton placement | Days to weeks | Tract drained, sphincter protected |
| Medical therapy trial | Weeks to months | Inflammation reduced, closure assessed |
| Imaging reassessment | Months | MRI or ultrasound confirms tract status |
| Definitive repair | Months | Sphincter-sparing surgery if indicated |
| Surveillance | Years | Recurrence monitoring |
Limitations and what remains uncertain
Fistula research is limited by inconsistent definitions of healing, small cohorts, and heterogeneous disease severity. Many studies report clinical closure without imaging confirmation, and long-term recurrence data are sparse. Predictions about which patient will heal with medical therapy alone remain imperfect. The honest summary is that fistulas in Crohn’s require individualized, staged care, and no single threshold or treatment works for every tract.